Answers are grounded in this paper and cite their sources.
It is crucial to pinpoint the metabolites that cause Crohn's disease (CD) and ulcerative colitis (UC) to comprehend their pathogenesis and identify possible targets for therapy. To achieve this goal, we performed the first metabolome-wide Mendelian randomization (MR) study of Japanese patients with CD and UC.
No takes yet. Share an insight, caveat, or question.
Naito et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: